Follow
Rayan Krishnan
Rayan Krishnan
Verified email at stanford.edu
Title
Cited by
Cited by
Year
Self-supervised learning in medicine and healthcare
R Krishnan, P Rajpurkar, EJ Topol
Nature Biomedical Engineering, 1-7, 2022
2242022
Retrieval-Based Chest X-Ray Report Generation Using a Pre-trained Contrastive Language-Image Model
M Endo, R Krishnan, V Krishna, AY Ng, P Rajpurkar
Machine Learning for Health, 209-219, 2021
572021
Evaluating progress in automatic chest x-ray radiology report generation
F Yu, M Endo, R Krishnan, I Pan, A Tsai, EP Reis, EKUN Fonseca, ...
Patterns 4 (9), 2023
322023
CheXphoto: 10,000+ Photos and Transformations of Chest X-rays for Benchmarking Deep Learning Robustness
NA Phillips, P Rajpurkar, M Sabini, R Krishnan, S Zhou, A Pareek, ...
Machine Learning for Health, 318-327, 2020
282020
Using LSTM and SARIMA Models to Forecast Cluster CPU Usage
L Nashold, R Krishnan
arXiv preprint arXiv:2007.08092, 2020
272020
Chexbreak: Misclassification identification for deep learning models interpreting chest x-rays
E Chen, A Kim, R Krishnan, J Long, AY Ng, P Rajpurkar
Machine Learning for Healthcare Conference, 103-125, 2021
42021
Radiology Report Expert Evaluation (ReXVal) Dataset
F Yu, M Endo, R Krishnan, I Pan, A Tsai, EP Reis, EKU Fonseca, H Lee, ...
32023
1773P Prediction of neoadjuvant chemotherapy response in muscle-invasive bladder cancer: A machine learning approach
E Shkolyar, H Bhambhvani, E Tiu, V Krishna, V Nimgaonkar, R Krishnan, ...
Annals of Oncology 33, S1348, 2022
12022
Corrigendum to “1773P Prediction of chemotherapy response in muscle-invasive bladder cancer: A machine learning approach”:[Annals of Oncology 32 (2022) S1348]
E Shkolyar, H Bhambhvani, E Tiu, V Krishna, V Nimgaonkar, R Krishnan, ...
Annals of Oncology 34 (5), 502, 2023
2023
44/# 219 Predicting response to platinum-based chemotherapy for tubo-ovarian high-grade serous carcinoma using an artificial intelligence histopathology platform
E Tiu, V Krishna, V Nimgaonkar, R Krishnan, H Bhambhvani, ...
International Journal of Gynecologic Cancer 32 (Suppl 3), 2022
2022
43/# 512 Assessing robustness of an artificial intelligence derived histological biomarker across different sites of disease and in serial sections in tubo-ovarian high-grade …
R Krishnan, E Tiu, V Krishna, V Nimgaonkar, H Bhambhvani, ...
International Journal of Gynecologic Cancer 32 (Suppl 3), 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–11